{"entity":{"id":"priya-rastogi","kind":"person","name":"Priya Rastogi","aka":[],"tldr":"Pittsburgh medical oncologist who serves as CEO and Medical Director of the NSABP Foundation, leading its breast cancer trial portfolio.","summary":"Priya Rastogi is Chief Executive Officer and Medical Director of the NSABP Foundation and Associate Professor of Medicine at the University of Pittsburgh. A breast medical oncologist, she was first author of the long-term update of the NSABP B-18 and B-27 neoadjuvant chemotherapy trials. She oversees the foundation's clinical trial operations and its participation in the NRG Oncology cooperative group.","asOf":"2026-09-10","links":[{"label":"Institution profile","url":"https://www.nsabp.org/about-us/the-team/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Rastogi+P%5BAuthor%5D"}],"tags":["leadership","clinician-scientist","breast cancer","clinical trials"],"related":[],"cancers":["breast-hr-positive","breast-her2-positive","tnbc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["nsabp-foundation"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Chief Executive Officer & Medical Director","institutionId":"nsabp-foundation","specialisms":["Breast cancer","Neoadjuvant therapy","Clinical trials"],"profiles":[{"label":"Institution profile","url":"https://www.nsabp.org/about-us/the-team/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Rastogi+P%5BAuthor%5D"}],"papers":[{"title":"Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27","journal":"Journal of Clinical Oncology","year":2008,"url":"https://doi.org/10.1200/JCO.2007.15.0235","doi":"10.1200/JCO.2007.15.0235"}]},"route":"/people/priya-rastogi/","neighbours":{"cancer":[{"id":"breast-her2-positive","kind":"cancer","name":"HER2-positive breast cancer","route":"/cancers/breast-her2-positive/"},{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"},{"id":"tnbc","kind":"cancer","name":"Triple-negative breast cancer (TNBC)","route":"/cancers/tnbc/"}],"company":[{"id":"nsabp-foundation","kind":"company","name":"NSABP Foundation","route":"/companies/nsabp-foundation/"}]}}